JournalTOCs

Expert Opinion on Therapeutic Patents
Journal Prestige (SJR): 0.926

Citation Impact (citeScore): 3
Number of Followers: 12

Hybrid journal * Containing 1 Open Access article(s) in this issue *
ISSN (Print) 1354-3776 - ISSN (Online) 1744-7674
Published by Taylor and Francis

[2600 journals]

Inventive step assessment of top selling monoclonal antibodies in Brazil
- .
  Expert Opinion on Therapeutic Patents2021-01-19T07:56:15Z
  DOI: 10.1080/13543776.2021.1873955
Acetylcholinesterase inhibitors for the treatment of Alzheimer’s disease
– a patent review (2016–present)
- .
  Expert Opinion on Therapeutic Patents2021-01-14T05:17:21Z
  DOI: 10.1080/13543776.2021.1874344
The therapeutic potential of PROTACs
- .
  Expert Opinion on Therapeutic Patents2021-01-12T07:50:37Z
  DOI: 10.1080/13543776.2021.1840553
An updated patent review of autotaxin inhibitors (2017–present)
- .
  Expert Opinion on Therapeutic Patents2021-01-12T01:05:06Z
  DOI: 10.1080/13543776.2021.1867106
Therapeutic approaches targeting the neurotensin receptors
- .
  Expert Opinion on Therapeutic Patents2021-01-08T03:21:29Z
  DOI: 10.1080/13543776.2021.1866539
Monocyclic beta–lactams for therapeutic uses: a patent overview
(2010–2020)
- .
  Expert Opinion on Therapeutic Patents2021-01-07T08:47:29Z
  DOI: 10.1080/13543776.2021.1865919
Soluble guanylate cyclase stimulators and their potential use: a patent
review
Open Access Article
- .
  Expert Opinion on Therapeutic Patents2021-01-04T06:27:39Z
  DOI: 10.1080/13543776.2021.1866538
Targeting PRC2 for the treatment of cancer: an updated patent review (2016
- 2020)
- .
  Expert Opinion on Therapeutic Patents2021-01-04T05:30:36Z
  DOI: 10.1080/13543776.2021.1841167
Repurposing drugs for the management of COVID-19
- .
  Expert Opinion on Therapeutic Patents2020-12-31T02:57:32Z
  DOI: 10.1080/13543776.2021.1861248
A patent review of transient receptor potential vanilloid type 1
modulators (2014–present)
- .
  Expert Opinion on Therapeutic Patents2020-12-30T10:58:20Z
  DOI: 10.1080/13543776.2021.1854225
Multicomponent reactions (MCR) in medicinal chemistry: a patent review
(2010-2020)
- .
  Expert Opinion on Therapeutic Patents2020-12-29T02:05:31Z
  DOI: 10.1080/13543776.2021.1858797
Recent progress in the development of β2 adrenergic receptor agonists: a
patent review (2015-2020)
- .
  Expert Opinion on Therapeutic Patents2020-12-23T09:36:38Z
  DOI: 10.1080/13543776.2021.1865312
Small-molecule BACE1 inhibitors: a patent literature review (2011 to 2020)
- .
  Expert Opinion on Therapeutic Patents2020-12-17T08:06:50Z
  DOI: 10.1080/13543776.2021.1832463
Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors for the
treatment of non-small cell lung cancer: a patent review (2014-present)
- .
  Expert Opinion on Therapeutic Patents2020-12-14T06:43:29Z
  DOI: 10.1080/13543776.2021.1860210
Protease inhibitors targeting the main protease and papain-like protease
of coronaviruses
- .
  Expert Opinion on Therapeutic Patents2020-12-12T05:34:51Z
  DOI: 10.1080/13543776.2021.1857726
Potential of microRNA based diagnostics and therapeutics in glioma: a
patent review
- .
  Expert Opinion on Therapeutic Patents2020-12-10T08:42:02Z
  DOI: 10.1080/13543776.2021.1837775
Inhibitors of RIP1 kinase: a patent review (2016–present)
- .
  Expert Opinion on Therapeutic Patents2020-12-04T05:14:56Z
  DOI: 10.1080/13543776.2021.1854729
An updated patent review of monoacylglycerol lipase (MAGL) inhibitors
(2018-present)
- .
  Expert Opinion on Therapeutic Patents2020-11-02T07:21:26Z
  DOI: 10.1080/13543776.2021.1841166
Small-molecule CSF1R kinase inhibitors; review of patents 2015-present
- .
  Expert Opinion on Therapeutic Patents2020-10-28T07:39:57Z
  DOI: 10.1080/13543776.2021.1839414
Searching for effective antiviral small molecules against influenza A
virus: A patent review
- .
  Expert Opinion on Therapeutic Patents2020-10-19T04:00:36Z
  DOI: 10.1080/13543776.2020.1831471
OX40 agonists for cancer treatment: a patent review
- .
  Expert Opinion on Therapeutic Patents2020-10-06T10:52:09Z
  DOI: 10.1080/13543776.2021.1825688
An updated patent review of anticancer Hsp90 inhibitors (2013-present)
- .
  Expert Opinion on Therapeutic Patents2020-10-05T04:08:08Z
  DOI: 10.1080/13543776.2021.1829595